Title	Publication Date	Language	Citations
Cathinone derivatives: A review of their chemistry, pharmacology and toxicology	2011/07/01	English	238
Analyses of second‐generation ‘legal highs’ in the UK: Initial findings	2010/08/01	English	188
From PCP to MXE: a comprehensive review of the non‐medical use of dissociative drugs	2014/03/26	English	162
Adulterants in illicit drugs: a review of empirical evidence	2010/12/29	English	151
Head‐twitch response in rodents induced by the hallucinogen 2,5‐dimethoxy‐4‐iodoamphetamine: a comprehensive history, a re‐evaluation of mechanisms, and its utility as a model	2012/04/19	English	136
The adverse health effects of chronic cannabis use	2013/07/08	English	135
The new drug phenomenon	2014/07/01	English	135
Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project	2016/02/17	English	133
Cannabis ‐ from cultivar to chemovar	2012/02/24	English	124
Phosphatidylethanol in blood (B‐PEth): A marker for alcohol use and abuse	2011/03/25	English	111
Detection of urinary metabolites of AM‐2201 and UR‐144, two novel synthetic cannabinoids	2012/10/01	English	110
A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK	2013/09/30	English	104
Screening for the synthetic cannabinoid JWH‐018 and its major metabolites in human doping controls	2010/09/24	English	100
The pharmacology and toxicology of the synthetic cathinone mephedrone (4‐methylmethcathinone)	2011/07/01	English	97
The emergence and analysis of synthetic cannabinoids	2011/02/21	English	96
New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon?	2014/01/27	English	94
Analysis of NRG ‘legal highs’ in the UK: identification and formation of novel cathinones	2010/12/29	English	92
In vitro metabolism studies on mephedrone and analysis of forensic cases	2012/05/09	English	84
Determination of acetylcholinesterase activity by the Ellman assay: A versatile tool for in vitro research on medical countermeasures against organophosphate poisoning	2011/10/13	English	82
SDS‐PAGE of recombinant and endogenous erythropoietins: benefits and limitations of the method for application in doping control	2009/01/01	English	81
A review of chemical ‘spot’ tests: A presumptive illicit drug identification technique	2017/11/10	English	81
Mitigation of post‐traumatic stress symptoms by Cannabis resin: A review of the clinical and neurobiological evidence	2012/06/26	English	80
A critical review of reports of endogenous psychedelic N, N‐dimethyltryptamines in humans: 1955–2010	2012/02/28	English	80
Confiscated black market products and nutritional supplements with non‐approved ingredients analyzed in the cologne doping control laboratory 2009	2010/10/26	English	78
Development of a rapid LC‐MS/MS method for direct urinalysis of designer drugs	2011/07/01	English	77
Health status of ayahuasca users	2012/07/01	English	75
Therapeutic potential of cannabinoid medicines	2013/09/04	English	74
Sewage‐based epidemiology in monitoring the use of new psychoactive substances: Validation and application of an analytical method using LC‐MS/MS	2015/02/06	English	74
Simple and rapid screening procedure for 143 new psychoactive substances by liquid chromatography‐tandem mass spectrometry	2015/05/14	English	72
Drug concentrations in post‐mortem femoral blood compared with therapeutic concentrations in plasma	2013/07/23	English	72